대한안과학회 학술대회 발표 연제 초록
 
발표일자: 2015년 11월 6일(금) ~ 11월 8일(일)
발표번호: P(e-poster)-250
발표장소: 킨텍스 제2전시장 7B홀
갑상선 안병증 환자에서 안와 방사선과 전신 스테로이드 병용 치료의 임상효과
연세대학교 의과대학 안과학교실 시기능개발연구소(1) / 경북대학교 의학전문대학원 안과학교실(2)
김지원(1)/손병재(2)/임형택(1)/윤진숙(1)
목적 : To compare the efficacy and safety of combination therapy with orbital irradiation and systemic steroids versus steroid monotherapy in the management of active Graves’ orbitopathy(GO) in Korean patients. 방법 : The clinical charts of 321 patients with active inflammation due to GO who received steroid pulse therapy with or without orbital radiotherapy between 2010 and 2014 were reviewed. Patients were divided into two treatment groups: 1) combined orbital radiotherapy and steroid pulse therapy(SRT group) and 2) steroid pulse therapy only(ST group).The clinical activity score(CAS); NOSPECS classification; ocular motility impairment; exophthalmos at 1,3,6, and 12 months after treatment and the change in extraocular muscle volume after treatment, measured by orbit computed tomography, were evaluated. 결과 : Sixty-eight patients were included in the SRT group, and 59 patients were in the ST group. Although both groups experienced a significant reduction in CAS and NOSPECS, the SRT group demonstrated significantly greater improvements in ocular motility impairment and exophthalmos. EOM volume was reduced after treatment in both groups; however, the change was significant in the SRT group. Compressive optic neuropathy after treatment developed in 0% of the SRT group and 3.4%(2/59) of the ST group. Reactivation of inflammation occurred in 11.8%(8/68) of the SRT group and 28.8%(17/59) of the ST group. 결론 : Orbital radiotherapy in combination with steroid treatment significantly improved ocular motility by reducing EOM volume in patients with active GO.
 
[돌아가기]